| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Durect Corp is a biopharmaceutical company. It develops pharmaceutical products based on two categories which include new chemical entities and drug delivery programs. The lead candidate for the company is DUR-928. Its pipeline products consist of DUR-928, RBP-7000, Posmir, Remoxy, Oradur, and others.
| |